Follow-up after breast cancer (surveillance after treatment) relies on a clinical examination every 3 to 6 months for 5 years, then once a year for life, and a yearly mammogram. In a woman with no symptoms, repeated scans and blood tumour markers are not useful. Follow-up also helps manage the effects of hormone therapy, prevent lymphoedema and support you with contraception, pregnancy and a return to normal life.
The end of active treatment (surgery, chemotherapy, radiotherapy) opens a new stage. Follow-up has several aims:
It is organised between the oncology team, your gynaecologist and your GP. This article complements our gynaecological cancer care page and our general article on breast cancer.
| Period | Appointment (clinical examination) | Imaging |
|---|---|---|
| Years 1 to 5 | Every 3 to 6 months | Yearly mammogram (± ultrasound), the first one a year after the initial mammogram and at least 6 months after the end of radiotherapy |
| After 5 years | Once a year, for life | Yearly mammogram |
This schedule is a baseline, adapted to each situation. A breast MRI may be offered for women with a genetic predisposition or breasts that are hard to assess on imaging.
A Cochrane review compared intensive follow-up (regular scans, bone scans, blood tests) with clinical follow-up plus mammography: intensive follow-up does not prolong survival or improve quality of life. French guidelines (INCa) therefore include no routine imaging or blood tests when there are no warning signs. However, any new symptom should lead to targeted tests.
Keep looking at and feeling your breasts, scar and armpits, including after mastectomy or reconstruction. Do not wait for your next appointment if you notice:
If you have sudden breathlessness, chest pain or a swollen, painful leg, in France call 15 (or your local emergency number): these signs may point to deep vein thrombosis or pulmonary embolism, the risk of which is increased by some treatments.
When the tumour had hormone receptors, hormone therapy is prescribed for at least 5 years, sometimes 7 to 10 years. It is important not to stop it without talking to your oncologist: it clearly reduces the risk of relapse.
It increases the risk of endometrial polyps and cancer in postmenopausal women, as well as the risk of deep vein thrombosis. Any vaginal bleeding after menopause should be checked promptly: a pelvic ultrasound and, if needed, a hysteroscopy with biopsy are carried out. See our article on bleeding after menopause. Without symptoms, a clinical check at least once a year is recommended, with no routine ultrasound.
They cause bone loss. A bone density scan is done at the start of treatment and then regularly; enough calcium and vitamin D, physical activity and sometimes a bone-protecting treatment are offered. Joint pain is common and can be relieved.
Hot flushes, vaginal dryness, pain during sex: non-hormonal solutions exist. Menopausal hormone therapy, however, is contraindicated. See our articles on hot flushes without hormones and vaginal dryness.

Lymphoedema is swelling of the arm on the side of the operation, caused by the removal of lymph nodes from the armpit. It is much rarer after the sentinel node technique alone than after axillary clearance, and it can appear months or years after surgery.
At the slightest swelling, see a doctor: early treatment by a trained physiotherapist (drainage, bandaging, compression sleeve) is more effective.
Hormonal contraception, both combined and progestogen-only (pill, implant, ring, hormonal IUD), is contraindicated after breast cancer. The recommended methods are the copper IUD, condoms or, if you do not want more children, tubal sterilisation. Contraception is still needed even if your periods stopped during chemotherapy, because ovulation can return, particularly on tamoxifen, which is harmful to an embryo.
According to current data, pregnancy after breast cancer does not increase the risk of recurrence. It is usually advised to wait at least 2 years after diagnosis, a period that varies with the risk of relapse and ongoing treatment. For women on hormone therapy, the international POSITIVE trial showed that temporarily pausing treatment after 18 to 30 months of hormone therapy, to try for a pregnancy, did not increase the short-term risk of relapse (3 years of follow-up); hormone therapy is then resumed. This plan is prepared with the oncologist and the obstetrician-gynaecologist, who will then follow the pregnancy together.
Gynaecological follow-up can be provided at the practice, in coordination with the oncology team treating you.
No, not if you have no symptoms. Follow-up relies on a clinical examination and a yearly mammogram; CT and bone scans are only ordered if there is a warning sign.
Guidelines do not advise routine testing during follow-up, because it does not improve survival and can cause needless worry.
No, it is contraindicated. Non-hormonal treatments exist for hot flushes and vaginal dryness.
For life, but it becomes lighter over time: it becomes yearly after 5 years, with a mammogram every year.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.